Ruth Plummer
Impact in
- Oncology top 0.5%
- PARP inhibition in cancer therapy
- Cancer-related Molecular Pathways
- HER2/EGFR in Cancer Research
- Molecular Biology top 2%
- DNA Repair Mechanisms
- Cancer therapeutics and mechanisms
- Cell death mechanisms and regulation
Papers in
- Oncology 143
- PARP inhibition in cancer therapy 50
- Colorectal Cancer Treatments and Studies 25
- Cancer Treatment and Pharmacology 24
- Cancer Immunotherapy and Biomarkers 21
- HER2/EGFR in Cancer Research 16
-
- DNA Repair Mechanisms 27
- Co-authors
- Hilary Calvert (31 shared papers)Mark R. Middleton (24 shared papers)Alan V. Boddy (11 shared papers)Johann S. de Bono (26 shared papers)Yvette Drew (18 shared papers)Richard H. Wilson (15 shared papers)Timothy A. Yap (13 shared papers)Nicola J. Curtin (12 shared papers)
- Journals
- Journal of Clinical Oncology (38 papers)Annals of Oncology (35 papers)British Journal of Cancer (19 papers)Clinical Cancer Research (13 papers)European Journal of Cancer (12 papers)
- Partner nations
- United KingdomUnited StatesFrance
In The Last Decade
Ruth Plummer
227 papers receiving 6.4k citations
Peers
Comparison fields: 5 of 123
- Oncology 3.3k
- Molecular Biology 3.2k
- Cancer Research 617
- Genetics 353
- Pulmonary and Respiratory Medicine 1.0k
Countries citing papers authored by Ruth Plummer
This map shows the geographic impact of Ruth Plummer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ruth Plummer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ruth Plummer more than expected).
Fields of papers citing papers by Ruth Plummer
This network shows the impact of papers produced by Ruth Plummer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ruth Plummer. The network helps show where Ruth Plummer may publish in the future.
Co-authors
The 25 scholars most cited alongside Ruth Plummer, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 238 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2011 | 344 | |
| 2 | 2008 | 324 | |
| 3 | 2008 | 307 | |
| 4 | 2010 | 306 | |
| 5 | 2007 | 206 | |
| 6 | 2019 | 193 | |
| 7 | 2013 | 157 | |
| 8 | 2015 | 155 | |
| 9 | 2017 | 143 | |
| 10 | 2019 | 140 | |
| 11 | 2011 | 139 | |
| 12 | 2016 | 137 | |
| 13 | 2002 | 130 | |
| 14 | 2019 | 127 | |
| 15 | 2011 | 109 | |
| 16 | 2018 | 107 | |
| 17 | 2016 | 106 | |
| 18 | 2013 | 103 | |
| 19 | 2009 | 102 | |
| 20 | 2016 | 101 |
About Ruth Plummer
Ruth Plummer is a scholar working on Oncology, Molecular Biology, Pulmonary and Respiratory Medicine, Immunology and Cancer Research, having authored 238 papers that have together received 6.6k indexed citations. Recurring topics across this work include PARP inhibition in cancer therapy (50 papers), DNA Repair Mechanisms (27 papers), Colorectal Cancer Treatments and Studies (25 papers), Cancer Treatment and Pharmacology (24 papers), Lung Cancer Treatments and Mutations (22 papers), Cancer Immunotherapy and Biomarkers (21 papers), HER2/EGFR in Cancer Research (16 papers) and Immunotherapy and Immune Responses (12 papers). The work is most often cited by research in Oncology (3.3k citations), Molecular Biology (3.2k citations), Cancer Research (617 citations), Genetics (353 citations) and Pulmonary and Respiratory Medicine (1.0k citations). Ruth Plummer has collaborated with scholars based in United Kingdom, United States and France. Frequent co-authors include Hilary Calvert, Mark R. Middleton, Alan V. Boddy, Johann S. de Bono, Yvette Drew, Richard H. Wilson, Timothy A. Yap, Nicola J. Curtin, Wolfgang Wick and Michael Weller. Their work appears in journals such as Journal of Clinical Oncology, Annals of Oncology, British Journal of Cancer, Clinical Cancer Research and European Journal of Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.